PRIMARY CUTANEOUS FOLLICLE CENTER LYMPHOMA

Clinical trials for PRIMARY CUTANEOUS FOLLICLE CENTER LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new PRIMARY CUTANEOUS FOLLICLE CENTER LYMPHOMA trials appear

Sign up with your email to follow new studies for PRIMARY CUTANEOUS FOLLICLE CENTER LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill tested for Tough-to-Treat blood cancers

Disease control Recruiting now

This is a first-in-human study to test the safety of a new oral drug called SGR-1505 in adults with various types of relapsed or hard-to-treat B-cell cancers, like non-Hodgkin lymphoma and chronic lymphocytic leukemia. The main goal is to find the highest dose patients can tolera…

Matched conditions: PRIMARY CUTANEOUS FOLLICLE CENTER LYMPHOMA

Phase: PHASE1 • Sponsor: Schrödinger, Inc. • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

PRIMARY CUTANEOUS FOLLICLE CENTER LYMPHOMA

Get alerted when new PRIMARY CUTANEOUS FOLLICLE CENTER LYMPHOMA trials appear

New pill tested for Tough-to-Treat blood cancers